Drug interactions
Brentuximab vedotin + Dexamethasone-tobramycin
Severity: Minor
Brentuximab vedotin and Dexamethasone-tobramycin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dexamethasone may induce CYP3A4 and lower exposure to the MMAE component released from brentuximab vedotin. The effect is expected to be modest and of uncertain clinical importance. Ophthalmic use yields little systemic exposure.
What this interaction means in plain words
Brentuximab vedotin and Dexamethasone-tobramycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Brentuximab vedotin belongs to Oncology; Dexamethasone-tobramycin belongs to Anti Bacterial.
Why it happens
CYP3A4 induction by dexamethasone may increase metabolism of free MMAE.
What to do
No dose change is needed; monitor treatment response when systemic dexamethasone is used long term.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab vedotin and Dexamethasone-tobramycin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexamethasone-tobramycin
Other interactions of Brentuximab vedotin
- Bleomycin + Brentuximab vedotin Contraindicated
- Brentuximab vedotin + Siponimod Major
- Apalutamide + Brentuximab vedotin Moderate
- Brentuximab vedotin + Clarithromycin Moderate
- Brentuximab vedotin + Imatinib Moderate
- Brentuximab vedotin + Isoniazid Moderate
Frequently asked questions
Can I take Brentuximab vedotin with Dexamethasone-tobramycin?
MediHelp rates the interaction as minor. Brentuximab vedotin and Dexamethasone-tobramycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dexamethasone may induce CYP3A4 and lower exposure to the MMAE component released from brentuximab vedotin. The effect is expected to be modest and of uncertain clinical importance. Ophthalmic use yields little systemic exposure.
How serious is the interaction between Brentuximab vedotin and Dexamethasone-tobramycin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; monitor treatment response when systemic dexamethasone is used long term.
What other medicines interact with Dexamethasone-tobramycin?
MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
